Microbio is proud to announce the appointment of Palex España, a leading provider of medical and diagnostic solutions, as its exclusive distributor in Spain.
This strategic collaboration represents a key milestone in Microbio’s international growth, enabling broader access to its cutting-edge technology across Europe. With Palex’s deep expertise and strong footprint in the Spanish healthcare sector, Microbio’s advanced diagnostic tools are set to make a significant impact on patient care throughout the region.
At the core of Microbio’s offering is InfectID™-BSI, a rapid molecular diagnostic test that identifies 26 pathogens responsible for >94% of bloodstream infections resulting in sepsis. Leveraging DNA melt curve analysis, InfectID™-BSI detects pathogens directly from blood samples without the need for culture, delivering results in just three hours. This CE-marked assay empowers clinicians to begin targeted treatment sooner, improving outcomes and supporting antimicrobial stewardship.
“We’re excited to partner with Palex, a company that shares our dedication to innovation and patient-centric healthcare,” said Johan Vanderhoeven, Chief Commercial Officer at Microbio. “Palex’s well-established presence and reputation in Spain make them an ideal partner to bring InfectID™-BSI and our future diagnostic products to this strategically important market.”
Jaume Clariana, IVD Business Unit Manager at Palex España added: “At Palex, we empower healthcare professionals and researchers with cutting-edge, customized technologies designed to make a real difference in people’s lives. Sepsis diagnosis has always been a strategic priority for us, which is why we’re thrilled to announce our new partnership with Microbio — a company passionately committed to advancing patient care through innovative solutions.